Certican derives Successful Result

.

Certican derives Successful Result

Surely, it was a good news for Novartis that it has been able to have positive result of its phase III clinical study of immune system drug known as Certican. The news was worth getting happy, as it has been found that the Swiss pharmaceutical company was trying to get everything right for last two years.

In addition, it has been said that the project is considered to be the biggest project that has been taken out by the company with regard to liver transplant. It has been found that the drug is quite effective in improving renal function among patients.

The data about the same was revealed at the meeting of American Association for the Study of Liver Diseases (AASLD), which is in its 63rd year. The drug, which has already received approval from European health authorities, is likely to get approval from the US health regulators Food and Drug Administration by the end of 2012.

"These results showed that treatment with Certican with reduced tacrolimus led to a clinically relevant retention of renal function compared to standard tacrolimus, with no compromise in rejection", said John Fung, who is positioned as director at Transplantation Center. It is expected that the drug is able to provide benefit to adults suffering from liver problem.


Latest News

Biggest Daily Climb Noted in the Oil Markets in Past Six Years
According to Sources Marchionne to Take over as Both CEO and Chairman of Ferrari
Consumer Spending and Inflation Drops in Japan Adding Pressure on Policymakers
Patterson Companies, Inc reports $29.7 million First Quarter Profit
Gap Announced by Beginning of Next year It will Phase Out On-Call Scheduling
Next Month Amazon Plans to Launch Its Video Streaming Service Tailored for Custo
Burger King Proposes to Create McWhopper with McDonald
Schlumberger Acquiring Cameron in a Cash and Stock Deal
Former J.P. Morgan Analyst Indicted on Federal Charges for Insider Trading
US President Barack Obama Flies to the Nevada Desert to Support the Growth of So
Public Service Commission Approves Ownership Transfer of Wind Project to Xcel En
Crude Oil Prices Firm but Close to Six Year Low; Asian Stocks Continue to Slide